GB/T 36136-2018
ActiveGeneral requirements of DNA array-based M.tuberculosis drug resistance detection
结核分枝杆菌耐药基因芯片检测基本要求
Application Summary AI generated
This standard specifies the general technical requirements for using DNA microarray technology to detect drug resistance genes in Mycobacterium tuberculosis. It is applied in clinical microbiology laboratories and healthcare settings for the rapid identification of mutations associated with resistance to first- and second-line anti-tuberculosis drugs. The standard ensures consistent and reliable testing procedures to guide effective treatment regimens for tuberculosis patients.
Related Standards
GB/T 19381-2003
General methods of test for medical closures of butyl rubber
GB/T 14214-2003
Spectacle frames--General requirements and test methods
GB/T 18375.5-2004
Prosthetics--Structural testing of lower-limb prostheses--Part 5:Supplementary structural tests
GB/T 18375.6-2004
Prosthetics--Structural testing of lower-limb prostheses--Part 6:Loading parameters of supplementary structural tests
GB/T 18375.7-2004
Prosthetics--Structural testing of lower-limb prostheses--Part 7:Test submission document
GB/T 19543-2004
Prostheses--Structural testing of hip units
GB/T 18375.8-2004
Prosthetics--Structural testing of lower-limb prostheses--Part 8:Test report
GB/T 19629-2005
Medical Electrical Equipment-Dosimeters with ionization chambers and/or semi-conductors as used in X-ray diagnostic imaging
Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.